Related Experiment Video
Updated: Sep 27, 2025

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
Stroke Incidence and Outcome in a Population With COVID-19
Moayd M Alkhalifah1, Ramzi Banda1, Shukri Alqudihy2
1Neurology Unit, Neurosciences Institute, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Insights
The 30-day stroke incidence in hospitalized COVID-19 patients was low at 0.2%. This study evaluated stroke occurrence and outcomes in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiology
Background:
- COVID-19 is linked to systemic thromboembolism, including stroke.
- Understanding stroke risk in SARS-CoV-2 positive patients is crucial.
Purpose of the Study:
- To evaluate the 30-day stroke incidence in patients with a positive SARS-CoV-2 PCR test.
- To describe the outcomes of COVID-19 patients who experienced stroke.
Main Methods:
- Retrospective study of hospitalized patients with positive SARS-CoV-2 PCR tests.
- Inclusion criteria: positive SARS-CoV-2 PCR, hospitalization, and stroke within 30 days of testing.
Main Results:
- 4301 patients tested positive for SARS-CoV-2; 1786 were hospitalized.
- 4 hospitalized patients developed stroke within 30 days (0.09% overall, 0.2% hospitalized).
- Stroke patients were older (mean age 78), had ischemic strokes, and comorbidities; 2 deaths occurred.
Conclusions:
- The 30-day incidence of stroke among COVID-19 patients is low.
- COVID-19 patients experiencing stroke had specific demographic and clinical characteristics.
Background And Purpose:
COVID-19 is associated with systemic thromboembolism including stroke. The study evaluated the 30-days stroke incidence in SARS-CoV-2 PCR positive patients and described the outcome of such patients.
Methods:
This is a retrospective study of consecutive patients with a positive SARS-CoV-2 PCR test between March 1st, 2020 and August 30th, 2020. The study included COVID-19 patients who were hospitalized and had a stroke within 30 days from the positive PCR test.
Results:
During the study period, there were 4301 patients with a positive SARS-CoV-2 PCR test. Of those, 1786 patients (41.5%) were hospitalized and 4 patients developed a stroke within 30 days. The 30-days stroke incidence was 0.09% and 0.2% of all and hospitalized patients, respectively. The mean age of stroke patients was 78 years and 2 died during the same hospitalization. The 4 patients had comorbidities, one had pre-existing atrial fibrillation and all had ischemic stroke.
Conclusion:
This study showed a low 30-day incidence of stroke among COVID-19 patients.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Bias in Epidemiological Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Types of Skewness
For instance, in the middle of a pandemic, the geographical distribution of vaccine coverage may be positively skewed towards populations in the global north countries. However,...

